H. Lundbeck: Longboard Pharmaceuticals Acquisition Expected to Close on Dec 2

Dow Jones02:06 ET

H. Lundbeck: Shares Representing 88.6% of Longboard Have Been Validly Tendered

Dow Jones02:06 ET

Bright Minds Initiated at Outperform by Baird, Longboard Takeover Cited

Seeking AlphaNov 26 10:22 ET

Hold Rating for Longboard Pharmaceuticals Amidst Acquisition Uncertainty and Speculative Risks

TipRanksNov 13 04:45 ET · Ratings

Express News | Longboard Pharmaceuticals Initiates Phase 3 Deep Ocean Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (Dees)

ReutersNov 12 08:30 ET

Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)

BusinesswireNov 12 08:30 ET